CT细胞外容积分数与心肌-管腔信号比诊断心脏淀粉样变性的比较
本研究回顾性纳入552例因疑似心力衰竭或心肌病行CT细胞外容积(ECV)分析的患者,比较CT衍生心肌ECV与延迟期心肌-管腔信号比对心脏淀粉样变性的诊断效能。结果显示两者诊断效能相当且优异,ECV最佳截断值37%时敏感度90%、特异度92%、AUC 0.97;
要点
- CT衍生ECV诊断心脏淀粉样变性效能优异,最佳截断值37%时AUC 0.97。
- 心肌-管腔信号比无需平扫CT和血细胞比容,诊断效能与ECV相当(AUC 0.96)。
- 疑似心脏淀粉样变性时,可利用延迟期心肌-管腔信号比作为简化替代指标。
核心结论
- CT衍生心肌ECV与延迟期心肌-管腔信号比在检测心脏淀粉样变性方面显示相当且优异的诊断效能。
研究设计与样本
- 回顾性研究纳入2018年1月至2021年7月因疑似心力衰竭或心肌病行CT ECV分析的患者552例(平均年龄69岁±14,男性295例),其中41例确诊心脏淀粉样变性。
- CT ECV通过常规经导管主动脉瓣置换术前规划心脏CT、房颤消融术前规划心脏CT或冠状动脉CTA附加平扫及延迟期心脏扫描进行量化。
诊断标准与关键数值
- CT ECV诊断心脏淀粉样变性的敏感度为90%(37/41,95%CI 77–97),特异度为92%(472/511,95%CI 90–95),最佳截断值37%,AUC 0.97(95%CI 0.96–0.99)。
- 心肌-管腔信号比诊断心脏淀粉样变性的敏感度为88%(36/41,95%CI 74–96),特异度为92%(469/511,95%CI 89–94),最佳截断值0.87,AUC 0.96(95%CI 0.94–0.97)。
临床应用与阅片要点
- 在延迟期心脏CT上测量心肌-管腔信号比(最佳截断值0.87)可作为无需平扫CT和血细胞比容的简化指标用于筛查心脏淀粉样变性。
- 若具备平扫及延迟期扫描条件,CT ECV(最佳截断值37%)同样提供优异的诊断效能。
局限性
- 本研究为单中心回顾性设计,心脏淀粉样变性患者仅41例,阳性样本量较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Large studies on the diagnostic performance of CT-derived myocardial extracellular volume fraction (ECV) for detecting cardiac amyloidosis are lacking. A simple and practical index as a surrogate for CT ECV would be clinically useful. Purpose To compare the diagnostic performances between CT-derived myocardial ECV and myocardium-to-lumen signal ratio for the detection of cardiac amyloidosis in a large patient sample. Materials and Methods This retrospective study included patients who underwent CT ECV analysis because of suspected heart failure or cardiomyopathy between January 2018 and July 2021. CT ECV was quantified using routine pre-transcatheter aortic valve replacement planning cardiac CT, pre-atrial fibrillation ablation planning cardiac CT, or coronary CT angiography with the addition of unenhanced and delayed phase cardiac CT scans. The diagnostic performances of CT ECV and myocardium-to-lumen signal ratio in delayed phase cardiac CT (a simplified index not requiring unenhanced CT and hematocrit) for detecting cardiac amyloidosis were evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity. Results Of 552 patients (mean age, 69 years ± 14 [SD]; 295 men), 41 had cardiac amyloidosis. The sensitivity of CT ECV for amyloidosis was 90% (37 of 41 patients [95% CI: 77, 97]), with a specificity of 92% (472 of 511 patients [95% CI: 90, 95]) and optimal ECV cutoff value of 37% (AUC, 0.97 [95% CI: 0.96, 0.99]). The sensitivity of myocardium-to-lumen signal ratio was 88% (36 of 41 patients [95% CI: 74, 96]), with a specificity of 92% (469 of 511 patients [95% CI: 89, 94]) and optimal myocardium-to-lumen signal ratio cutoff value of 0.87 (AUC, 0.96 [95% CI: 0.94, 0.97]; P = .27 for comparison with ECV). Conclusion CT-derived myocardial extracellular volume fraction and myocardium-to-lumen signal ratio showed comparable and excellent diagnostic performance in detecting cardiac amyloidosis in a large patient sample. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Williams in this issue.
引用
- Kidoh, Oda, Takashio, et al. CT Extracellular Volume Fraction versus Myocardium-to-Lumen Signal Ratio for Cardiac Amyloidosis. Radiology. 2022. PMID: 36255307. doi:10.1148/radiol.220542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。